Condition

Blastic Plasmacytoid Dendritic Cell Neoplasm

Treatments and trials tagged Blastic Plasmacytoid Dendritic Cell Neoplasm, with the same country and access zoom as New Developments.

All New Developments

Blastic Plasmacytoid Dendritic Cell Neoplasm breakthroughs

All countries United States Canada United Kingdom Japan China Australia Switzerland European Union Newest Patient Stories

FDA ApprovedUnited States

New Treatment for a Rare Blood Cancer (BPDCN) in Adults

Decnupaz (pivekimab sunirine-pvzy) — CD123 ADC for adults with BPDCN

FDA approval on 27 May 2026 for Decnupaz (pivekimab sunirine-pvzy) — a CD123-directed antibody and alkylating-agent conjugate — for adults with…

This is for adults with BPDCN — an ultra-rare, aggressive blood/bone-marrow cancer that often involves skin,…

September 11, 2026